IL40458A0 - Novel pyrimidinones and hydroxypyrimidines,their preparation and pharmaceutical compositions containing them - Google Patents
Novel pyrimidinones and hydroxypyrimidines,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL40458A0 IL40458A0 IL40458A IL4045872A IL40458A0 IL 40458 A0 IL40458 A0 IL 40458A0 IL 40458 A IL40458 A IL 40458A IL 4045872 A IL4045872 A IL 4045872A IL 40458 A0 IL40458 A0 IL 40458A0
- Authority
- IL
- Israel
- Prior art keywords
- hydroxypyrimidines
- pyrimidinones
- novel
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19400671A | 1971-10-29 | 1971-10-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL40458A0 true IL40458A0 (en) | 1972-11-28 |
IL40458A IL40458A (en) | 1976-05-31 |
Family
ID=22715935
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL40458A IL40458A (en) | 1971-10-29 | 1972-09-28 | Pyrimidinones,their preparation and pharmaceutical compositions containing them |
IL48790A IL48790A (en) | 1971-10-29 | 1976-01-05 | Hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL48790A IL48790A (en) | 1971-10-29 | 1976-01-05 | Hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them |
Country Status (25)
Country | Link |
---|---|
JP (2) | JPS5337870B2 (en) |
AR (2) | AR198798A1 (en) |
AT (2) | AT321308B (en) |
AU (1) | AU467600B2 (en) |
BE (1) | BE790125A (en) |
CA (1) | CA980778A (en) |
CH (2) | CH555832A (en) |
DE (3) | DE2248741C3 (en) |
DK (1) | DK131465B (en) |
EG (1) | EG11013A (en) |
ES (2) | ES407730A1 (en) |
FI (1) | FI55503C (en) |
FR (1) | FR2157865B1 (en) |
GB (2) | GB1377720A (en) |
IE (1) | IE37043B1 (en) |
IL (2) | IL40458A (en) |
LU (1) | LU66304A1 (en) |
NL (1) | NL166470C (en) |
NO (1) | NO136574C (en) |
PH (2) | PH10129A (en) |
PL (2) | PL84634B1 (en) |
SE (2) | SE393376B (en) |
SU (2) | SU498908A3 (en) |
YU (2) | YU35125B (en) |
ZA (1) | ZA727362B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151912U (en) * | 1979-04-17 | 1980-11-01 | ||
JPS5752409Y2 (en) * | 1979-11-05 | 1982-11-15 | ||
DE3222914A1 (en) * | 1982-06-18 | 1983-12-22 | Beiersdorf Ag, 2000 Hamburg | SUBSTITUTED 5-PHENYLTHIO-6-AMINO-PYRIMIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE, AND PREPARATIONS CONTAINING THESE COMPOUNDS |
JPH0655686B2 (en) * | 1988-08-30 | 1994-07-27 | 宇部興産株式会社 | Process for producing p-bromophenoxyacetaldehyde dialkyl acetals |
NZ565955A (en) | 2005-08-22 | 2011-08-26 | Melior Pharmaceuticals I Inc | Methods and formulations for modulating lyn kinase activity and treating related disorders |
US8552184B2 (en) | 2008-07-03 | 2013-10-08 | Melior Pharmaceuticals I, Inc. | Compounds and methods for treating disorders related to glucose metabolism |
US20130158055A1 (en) | 2010-05-28 | 2013-06-20 | Andrew G. Reaume | Prevention Of Pancreatic Beta Cell Degeneration |
NZ758966A (en) | 2017-04-10 | 2024-08-30 | Board Of Supervisors Of Louisiana State Univ And Agricultural And Mechanical College | Treatment of adipocytes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2913462A (en) * | 1959-11-17 | Eahl h | ||
GB951432A (en) * | 1959-03-17 | 1964-03-04 | Wellcome Found | Pyrimidine derivatives and the manufacture thereof |
-
0
- BE BE790125D patent/BE790125A/en not_active IP Right Cessation
-
1972
- 1972-02-18 GB GB5005373A patent/GB1377720A/en not_active Expired
- 1972-02-18 GB GB774872A patent/GB1377308A/en not_active Expired
- 1972-09-25 SE SE7212358A patent/SE393376B/en unknown
- 1972-09-28 IL IL40458A patent/IL40458A/en unknown
- 1972-09-28 AU AU47228/72A patent/AU467600B2/en not_active Expired
- 1972-10-02 PH PH13959A patent/PH10129A/en unknown
- 1972-10-05 DE DE2248741A patent/DE2248741C3/en not_active Expired
- 1972-10-05 DE DE2264657A patent/DE2264657C2/en not_active Expired
- 1972-10-05 DE DE2264374A patent/DE2264374C3/en not_active Expired
- 1972-10-06 AT AT858972A patent/AT321308B/en not_active IP Right Cessation
- 1972-10-06 AT AT00933/74A patent/AT320656B/en not_active IP Right Cessation
- 1972-10-12 FI FI2825/72A patent/FI55503C/en active
- 1972-10-12 YU YU2551/72A patent/YU35125B/en unknown
- 1972-10-13 NO NO3686/72A patent/NO136574C/en unknown
- 1972-10-13 SU SU1839308A patent/SU498908A3/en active
- 1972-10-16 JP JP10279972A patent/JPS5337870B2/ja not_active Expired
- 1972-10-16 FR FR7236560A patent/FR2157865B1/fr not_active Expired
- 1972-10-16 PL PL1972158297A patent/PL84634B1/pl unknown
- 1972-10-16 CH CH1507872A patent/CH555832A/en not_active IP Right Cessation
- 1972-10-16 PL PL1972174103A patent/PL89852B1/pl unknown
- 1972-10-16 DK DK510072AA patent/DK131465B/en not_active IP Right Cessation
- 1972-10-16 CA CA153,956A patent/CA980778A/en not_active Expired
- 1972-10-16 NL NL7213959.A patent/NL166470C/en not_active IP Right Cessation
- 1972-10-16 ZA ZA727362A patent/ZA727362B/en unknown
- 1972-10-16 CH CH165674A patent/CH549579A/en not_active IP Right Cessation
- 1972-10-16 IE IE1398/72A patent/IE37043B1/en unknown
- 1972-10-16 LU LU66304A patent/LU66304A1/xx unknown
- 1972-10-18 ES ES407730A patent/ES407730A1/en not_active Expired
- 1972-10-19 EG EG431/72A patent/EG11013A/en active
- 1972-10-23 AR AR244763A patent/AR198798A1/en active
-
1973
- 1973-07-12 AR AR249053A patent/AR196263A1/en active
-
1974
- 1974-03-26 SU SU2008490A patent/SU505362A3/en active
-
1975
- 1975-04-15 ES ES436624A patent/ES436624A1/en not_active Expired
- 1975-05-06 SE SE7505279A patent/SE397090B/en unknown
- 1975-11-21 PH PH17784A patent/PH11594A/en unknown
-
1976
- 1976-01-05 IL IL48790A patent/IL48790A/en unknown
-
1978
- 1978-02-08 JP JP1336078A patent/JPS53116386A/en active Granted
-
1979
- 1979-04-25 YU YU991/79A patent/YU36295B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL45492A0 (en) | New pyrimidines,their preparation and pharmaceutical compositions containing them | |
IL38687A (en) | Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them | |
IL40686A0 (en) | Triazinone derivatives,their preparation and pharmaceutical compositions containing them | |
IL36237A0 (en) | Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them | |
IL39341A0 (en) | Novel thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them | |
IL38705A0 (en) | Novel pyridazinones,their preparation and pharmaceutical compositions containing them | |
IL40184A0 (en) | 5-cinnamoyl-benzofurans,their preparation and pharmaceutical compositions containing them | |
IL43001A0 (en) | Novel 4-biphenylyl-alcohols,their preparation and pharmaceutical compositions containing them | |
IL37598A0 (en) | Bis-chromonyloxy compounds,their preparation and pharmaceutical compositions containing them | |
IL39845A0 (en) | Novel quinazolinone derivatives,their preparation and pharmaceutical compositions containing them | |
IL40458A0 (en) | Novel pyrimidinones and hydroxypyrimidines,their preparation and pharmaceutical compositions containing them | |
IL49286A0 (en) | Novel 1-iodo-1-trans-alkenes,their preparation and pharmaceutical compositions containing them | |
IL40572A0 (en) | Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them | |
ZA725890B (en) | Pyrimidine derivatives and pesticidal compositions containing them | |
IL40559A0 (en) | Novel pyrido(2,3-d)pyrimidines their preparation and pharmaceutical compositions containing them | |
IL36743A (en) | Phenylaminoalkanes,their preparation and pharmaceutical compositions containing them | |
IL37588A0 (en) | Pyrimidoisoquinolines,their preparation and pharmaceutical compositions containing them | |
IL40886A0 (en) | Novel benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
IL41200A0 (en) | Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them | |
IL40362A0 (en) | Novel 4-oxo-4h-1-benzopyran and-thiabenzopyran derivatives,their preparation and pharmaceutical compositions containing them | |
IL38440A0 (en) | Substituted dioxypiperidines,their preparation and pharmaceutical compositions containing them | |
IL41034A0 (en) | Novel 6-aza-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them | |
IL37047A0 (en) | Substituted amidines,their preparation and pharmaceutical compositions containing them | |
IL45865A0 (en) | 4-oxo-2-imidazolidinylidene ureas,their preparation and pharmaceutical compositions containing them | |
IL39355A0 (en) | Androstan-17beta-yl-acrylonitrile derivatives,their preparation and pharmaceutical compositions containing them |